Bicycle Therapeutics Ltd
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Bicycle Therapeutics Ltd
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.
/ 
Frequently asked questions
To buy Bicycle Therapeutics Ltd stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Bicycle Therapeutics Ltd by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Bicycle Therapeutics Ltd is BCYC:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Bicycle Therapeutics Ltd has its primary listing on NASDAQ. You can trade Bicycle Therapeutics Ltd with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Bicycle Therapeutics Ltd is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Bicycle Therapeutics Ltd as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Bicycle Therapeutics Ltd.